In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.
about
Detection of drug-drug interactions by modeling interaction profile fingerprintsSimilarity-based modeling in large-scale prediction of drug-drug interactionsA numerical method for analysis of in vitro time-dependent inhibition data. Part 1. Theoretical considerationsModulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans.Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testingA simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data.A novel in vitro approach for simultaneous evaluation of CYP3A4 inhibition and kinetic aqueous solubility.The roles of carboxylesterase and CYP isozymes on the in vitro metabolism of T-2 toxin.Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method.Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.Carbonated soft drinks alter hepatic cytochrome P450 isoform expression in Wistar rats.Metabolic-based drug-drug interactions prediction, recent approaches for risk assessment along drug development.Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes.Progress in Prediction and Interpretation of Clinically Relevant Metabolic Drug-Drug Interactions: a Minireview Illustrating Recent Developments and Current Opportunities.Structure–function relationships of inhibition of mosquito cytochrome P450 enzymes by flavonoids of Andrographis paniculata.Microsomal cytochrome P450 as a target for drug discovery and repurposing.Biomarker exposure-response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX-2 inhibitor.Inhibition against mosquito cytochrome P450 enzymes by rhinacanthin-A, -B, and -C elicits synergism on cypermethrin cytotoxicity in Spodoptera frugiperda cells.Predicting drug interaction potential with a physiologically based pharmacokinetic model: a case study of telithromycin, a time-dependent CYP3A inhibitor.High-throughput fluorescence assay of cytochrome P450 3A4Prediction of drug-drug interactions with carbamazepine-10,11-epoxide using a new in vitro assay for epoxide hydrolase inhibition.Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes.Synergy between rhinacanthins from Rhinacanthus nasutus in inhibition against mosquito cytochrome P450 enzymes.High-throughput fluorescence assay of cytochrome P450 3A4.INDI: a computational framework for inferring drug interactions and their associated recommendations.IC50-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4.Characterization of mosquito CYP6P7 and CYP6AA3: differences in substrate preference and kinetic properties.Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity.Direct and quantitative evaluation of the major human CYP contribution (fmCYP) to drug clearance using the in vitro Silensomes™ model.Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII8-12.The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2D6 Substrates.Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A.The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo.
P2860
Q28487875-EB7EB791-D760-4E1D-BC97-2CCB08CBD475Q28647954-898F3F30-CE00-47A2-9BF5-98E8E8034985Q30831869-26CE4C8C-B635-449F-8EA2-86FFCE470C10Q33566153-B9218DE0-6B9B-4898-AA14-71FC1CC206E2Q33596274-6B89CDB4-53CD-44FE-A6D9-9D0CAC133369Q33939558-399DED34-352A-4F32-958F-2E5F2BFE2B90Q34514087-9215D9ED-533A-4CE4-800A-90E0E5C9ABBBQ35313471-1DD3C6E2-D589-41E3-AA96-071D25476C52Q35810068-0BBB76B4-F695-4A52-BC6B-01C0928006D2Q36205082-1704EA11-7C23-4654-89AD-34312AC93DA4Q36320218-21D4F8EB-AB4A-441C-B023-AE85DA78E06DQ37406300-A514F625-D538-4591-8439-B4156801ADD1Q37965706-72EF094B-76B4-49E8-A762-578E800D2022Q37998136-B723CBF2-DA6C-45D7-A809-659F4F9FD532Q38668469-39070F71-F471-4035-BC33-0894EE30878DQ38928302-72B80FA6-9923-4F95-8549-A3D00CE53DCDQ38976232-7B0A443B-F656-4066-869C-6FE2227229BCQ39000644-82570584-2D87-4603-B974-C6D037A5C45AQ39183979-F4085497-4B76-4FFE-AC4D-2896929CB85DQ39268518-2FA4FBB6-614C-44A8-9E90-C103C0506C82Q39643626-41F7642F-E94B-417E-8D79-275129AB28C2Q39693962-6D8E98DB-5AF7-452E-B950-5D3CF33626DBQ39952608-4D6D34E6-B040-468E-91D8-4EF46A6317B1Q40156484-8E5ADB0B-8F7C-4ECA-BAB6-F3071E7CF0D3Q41680453-B6B230B4-ED93-44F2-B85D-99F3BCAD775AQ41998614-FE799A7A-DDF8-4E42-8235-D66D435D694BQ42082468-DEF4E75F-51CD-45B0-ADFA-F3873AFB4AD3Q42280497-AA317BE4-B1BD-44B1-B62B-E905AD1E205DQ43129481-AB9BC247-909A-4BF5-B5DB-9305B7CA9B7EQ44156765-1045E09C-DF6C-4372-9069-A817188EDAD8Q48049878-C08D9260-4BBF-44D9-824E-6530233B2E13Q49345918-66D996A0-D4FB-4E93-A4A6-29BF0BC1EC6FQ50087921-87B6603B-29F0-40BE-991B-868722CB1401Q51825953-6525674F-32B5-40B5-8D79-2BA834468F5AQ52334679-C2D92A2A-B3C3-42B3-AF09-436102E45957Q55426998-C87DFAF7-2342-4709-AA3A-6EB335D24576
P2860
In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro evaluation of reversi ...... icting drug-drug interactions.
@en
In vitro evaluation of reversi ...... icting drug-drug interactions.
@nl
type
label
In vitro evaluation of reversi ...... icting drug-drug interactions.
@en
In vitro evaluation of reversi ...... icting drug-drug interactions.
@nl
prefLabel
In vitro evaluation of reversi ...... icting drug-drug interactions.
@en
In vitro evaluation of reversi ...... icting drug-drug interactions.
@nl
P2860
P1433
P1476
In vitro evaluation of reversi ...... icting drug-drug interactions.
@en
P2093
Hongjian Zhang
Stephen Fowler
P2860
P2888
P304
P356
10.1208/S12248-008-9042-7
P407
P577
2008-06-01T00:00:00Z
P5875
P6179
1046870170